evenfolio
iSharesUCITS · IrelandEquityAccumulating

iShares Nasdaq US Biotechnology UCITS ETF (BTEC) UCITS

Price (USD)
$10.48
—13 Nov 2026
Share class assets
$1.3B
This share class
Expense ratio
0.35%
Per year
Distribution
Accumulating
USD share class
3Y CAGR
25.4%+9.8%
Category 15.6%
5Y CAGR
8.7%+4.3%
Category 4.4%

$10.48—13 Nov 2026

Fund

Class size
$1.3B
Expense
0.35%
Class
Acc · USD

Return

1Y
30.4%
3Y
25.4%
5Y
8.7%
Launch
9.5%
Loading NAV history…
iShares Nasdaq US Biotechnology UCITS ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation
—
Maximum drawdown
—
Sharpe ratio
—
Sortino ratio
—
Beta
—
Alpha
—
R²
—
Information ratio
—
Upside capture
—
Downside capture
—
Tracking error
—
Trailing returns compared with benchmark
Period1M3M6MYTD1Y3YCAGR5YCAGR10YCAGRLaunchCAGR
ETF+4.2%+7.0%+22.8%+24.5%+30.4%+25.4%+8.7%—+9.5%
Health average5.9%8.4%23.6%16.2%19.4%15.6%4.4%9.7%7.3%
Difference-1.6%-1.5%-0.8%+8.3%+11.0%+9.8%+4.3%—+2.2%

ETF details

Issuer
iShares
Type
Equity
Category
Health
Index
Nasdaq Biotechnology
Ticker
BTEC
Other tickers
BTEK, 2B70
ISIN
IE00BYXG2H39
WKN
A2DWAW
Domicile
Ireland
Share class currency
USD
Currency hedging
Unhedged
Distribution
Accumulating
Price history since
24 Nov 2017 (9.0 years)
Expense ratio
0.35%
Share class assets
$1.3B

Prices and returns in US dollars as of 13 Nov 2026, from the fund's Xetra listing (2B70) at each day's exchange rate; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other equity UCITS ETFs

Other equity UCITS ETFs, near this one in size.

Search

Search funds, ETFs, stocks, pages and tools